WHO ICTRP trial
Effect of anti-aging tablets on improving cognitive function of Mild and…
ChiCTR2100054713 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100054713 |
|---|---|
| Public title | Effect of anti-aging tablets on improving cognitive function of Mild and moderate Alzheimer's disease |
| Scientific title | Effect of anti-aging tablets on improving cognitive function of Mild and moderate Alzheimer's disease |
| Primary sponsor | Hangzhou Seventh People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Alzheimer's disease |
| Interventions | Donepezil + anti-aging tablets (experimental group):Donepezil + anti-aging tablets;donepezil + anti-aging tablets Placebo group(control group) :donepezil + anti-aging tablets Placebo group |
| Registration date | Dec 24, 2021 |
| Target size | Donepezil + anti-aging tablets (experimental group):15;donepezil + anti-aging… |
| Secondary IDs | ChiMCTR2100005443 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: